Literature DB >> 31032895

Cannabinoids and their actions: An update.

Stephen P H Alexander1, Francisco Molina-Holgado2.   

Abstract

LINKED ARTICLES: This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31032895      PMCID: PMC6487553          DOI: 10.1111/bph.14627

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.

Authors:  Mireille Alhouayek; Linda Rankin; Sandra Gouveia-Figueira; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2018-02-05       Impact factor: 8.739

Review 2.  The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.

Authors:  Javier Fernández-Ruiz
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

Review 3.  Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells.

Authors:  Moises Garcia-Arencibia; Eduardo Molina-Holgado; Francisco Molina-Holgado
Journal:  Br J Pharmacol       Date:  2018-06-22       Impact factor: 8.739

4.  The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner.

Authors:  Kieran Rea; Fiona McGowan; Louise Corcoran; Michelle Roche; David P Finn
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

5.  Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis.

Authors:  Francisco Espejo-Porras; Laura García-Toscano; Carmen Rodríguez-Cueto; Irene Santos-García; Eva de Lago; Javier Fernandez-Ruiz
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

Review 6.  Joint problems arising from lack of repair mechanisms: can cannabinoids help?

Authors:  Natalia Malek; Katarzyna Starowicz
Journal:  Br J Pharmacol       Date:  2018-04-22       Impact factor: 8.739

7.  Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.

Authors:  Martin A Sticht; David J Lau; Catherine M Keenan; Jean-Baptiste Cavin; Maria Morena; Venkata Kiran Vemuri; Alexandros Makriyannis; Benjamin F Cravatt; Keith A Sharkey; Matthew N Hill
Journal:  Br J Pharmacol       Date:  2018-08-22       Impact factor: 8.739

8.  Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.

Authors:  Fabio Arturo Iannotti; Ester Pagano; Aniello Schiano Moriello; Filomena Grazia Alvino; Nicolina Cristina Sorrentino; Luca D'Orsi; Elisabetta Gazzerro; Raffaele Capasso; Elvira De Leonibus; Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2018-09-09       Impact factor: 8.739

9.  Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine.

Authors:  Pedro H Gobira; Ana C Oliveira; Julia S Gomes; Vivian T da Silveira; Laila Asth; Juliana R Bastos; Edleusa M Batista; Ana C Issy; Bright N Okine; Antonio C de Oliveira; Fabiola M Ribeiro; Elaine A Del Bel; Daniele C Aguiar; David P Finn; Fabricio A Moreira
Journal:  Br J Pharmacol       Date:  2018-09-14       Impact factor: 8.739

Review 10.  Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance.

Authors:  Barbara Malinowska; Marek Toczek; Anna Pędzińska-Betiuk; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

View more
  1 in total

Review 1.  Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.

Authors:  Ming Tatt Lee; Ken Mackie; Lih-Chu Chiou
Journal:  Br J Pharmacol       Date:  2021-12-07       Impact factor: 9.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.